GLP-1s like Wegovy and Zepbound have taken the spotlight, especially after Oprah Winfrey highlighted them as pivotal to her weight loss journey on a recent episode of "Shame, Blame, and the Weight Loss Revolution."

But the burning question remains: How long should one stick to Wegovy or Zepbound? Is it a lifelong commitment? Join us in this episode as Dr. Linda Anegawa, Chief Medical Officer for Noom and a seasoned expert with over two decades of experience in primary care and obesity medicine, tackles this pressing question.

We dive into common misconceptions surrounding these medications, exploring the risks of starting and stopping them, potential dependency issues, and other crucial insights. Learn how GLP-1s function, their side effects, and the broader implications for individuals contemplating or currently using Wegovy and Zepbound for weight management.

Don't miss out on this enlightening discussion that aims to equip you with a comprehensive understanding of these groundbreaking weight management options. Tune in now for invaluable insights from Dr. Linda Anegawa.
.
More from The Dr. Francavilla Show brand:

Website https://www.thedrfrancavillashow.com/
Podcast https://www.thedrfrancavillashow.com/...
Facebook   / 100086226630098  
Twitter   / dr_francavilla  
Instagram   / doctorfrancavilla  
Instagram for Clinicians   / helpyourpatientsloseweight  
Tools for Clinicians https://www.helpyourpatientsloseweigh...